Professional Guidelines. Few controlled studies are available to guide treatment strategies in dermatomyositis (DM), and treatment recommendations for DM have mostly been based on case series ...

British Society for Rheumatology guideline on management of ... Patil A, Lu J, Kassir M, Babaei M, Goldust M. Adult and juvenile dermatomyositis treatment. J Cosmet Dermatol. 2023 Feb;22(2):395 ...

Guidelines First Presented in 2022 and Published in 2023. ... Cancer Screening Guidelines for Patients With Dermatomyositis Reveal High Sensitivity But Low Specificity - Medscape - October 03, 2024.

Dermatomyositis Treatment You can’t cure this condition, but you can treat your skin and muscle symptoms. You may need to see more than one doctor or medical professional, depending on your ...

TOPLINE: Treatment with dazukibart, a monoclonal antibody targeting interferon beta, yielded a rapid reduction in dermatomyositis disease activity in adults with skin-predominant and muscle ...

The dermatomyositis market is expected to witness steady growth over the next decade, driven by increasing awareness, improved diagnostic tools, and advancements in treatment options. The rising ...

Dermatomyositis is more likely to develop during childhood. While these are rare conditions, early detection and treatment are important to help prevent disease progression and complications.

Dermatomyositis is a rare muscular condition that requires lifelong treatment. This condition may lead to other health complications, affecting various body parts, such as the skin, lungs, and heart.

The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

US-based biotechnology company Priovant Therapeutics has finished enrolling subjects in a Phase III trial of brepocitinib, a new drug candidate designed to treat dermatomyositis. The double-blind ...

Treatment for Dermatomyositis. Treatment aims to suppress the autoimmune response, alleviate symptoms, and prevent complications. Corticosteroids are often the first line of treatment to reduce ...

Juvenile dermatomyositis (JDM) is a kind of arthritis that happens in kids. It's a rare disease that causes inflammation and swelling of the muscles and blood vessels under the skin. It may also ...